Long-term Follow-Up of Participants of the Phase II Study That Evaluated Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis (ASSET Trial) Sarsam, N., Johnson, S. R., Chung, L., Kafaja, S., Pope, J., Domsic, R., Mayes, M., Sandorfi, N., Steen, V., Castelino, F., Hant, F., Huang, S., Khanna, D. WILEY. 2022: 3009-3011

View details for Web of Science ID 000877386504021